Founder Lodge | Curve Therapeutics raises $51,183,495 at Series A …

Feb 28, 2024 · Curve Therapeutics raises $51,183,495 at Series A on 2024-02-28 in Biotechnology Research, industry founded/co-founded by Simon Kerry ... Series B. 1 …

CouponFollow Extension

$51183495
OFF

Founder Lodge | Curve Therapeutics Raises $51,183,495 At Series A …

6 days from now

Feb 28, 2024 · Curve Therapeutics raises $51,183,495 at Series A on 2024-02-28 in Biotechnology Research, industry founded/co-founded by Simon Kerry ... Series B. 1 …

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Curve Therapeutics raised $51,183,495 in Series A-Congrats Simon Kerry Full Round ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Curve Therapeutics raised $51,183,495 in …

linkedin.com

$50
OFF

Curve Therapeutics Secures Over $50 Million To Accelerate Its …

6 days from now

Mar 15, 2024 · Curve Therapeutics, a biotech developing an intracellular screening platform addressing complex disease targets, has closed its £40.5 million Series A financing. Pfizer …

thepharmanavigator.com

£40
OFF

Curve Therapeutics Raises £40.5 Million To Turbocharge Discovery ...

6 days from now

Feb 27, 2024 · Curve Therapeutics is a private biotechnology company pioneering a revolutionary intracellular screening platform to enable the discovery of innovative therapeutics that address …

prnewswire.com

£40
OFF

Curve Therapeutics Raises £40.5 Million To Turbocharge Discovery ...

6 days from now

Southampton, UK, 27 February 2023 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing …

adventls.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Curve raised $71,137,000 in Series C-Congrats Shachar Full ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Kenai Therapeutics raised $28,000,000 in Series A-Congrats Howard …

linkedin.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

VC investments in the second half of 2022 saw a steady stream of biotech fundraises over $30 million. These included Kriya Therapeutics which is riding on $150M to a series C round first …

linkedin.com

$115000000
OFF

Founder Lodge | Axonis Therapeutics Raises $115,000,000 At Series …

6 days from now

Oct 31, 2024 · Series A; $115,000,000 ; Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the …

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Nocion Therapeutics, Inc. raised $62,000,000 in Series B-Congrats Rick Batycky Full Round Info: https://lnkd.in/gSUiy2C8 Round Investors: Arkin Bio Capital…

linkedin.com

$85000000
OFF

Founder Lodge | MBrace Therapeutics Raises $85,000,000 At Series …

6 days from now

Nov 15, 2023 · MBrace Therapeutics raises $85,000,000 at Series B on 2023-11-15 in Biotechnology Research, industry founded/co-founded by Isan Chen

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Kenai Therapeutics raised $28,000,000 in Series A-Congrats Howard Federoff Full Round Info: ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Carmot spinoff Kimia raises $55M; …

linkedin.com

$12000000
OFF

Founder Lodge | Tempo Therapeutics Raises $12,000,000 At Series …

6 days from now

Mar 21, 2024 · Tempo Therapeutics raises $12,000,000 at Series A on 2024-03-21 in Biotechnology Research, industry founded/co-founded by Westbrook Weaver ... Series A; …

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Capstan Therapeutics raised $175,000,000 in Series B-Congrats Laura Shawver Full Round Info: ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Fantastic series B fund raise to …

linkedin.com

$175000000
OFF

Founder Lodge | Capstan Therapeutics Raises $175,000,000 At …

6 days from now

Mar 21, 2024 · Capstan Therapeutics raises $175,000,000 at Series B on 2024-03-21 in Biotechnology Research, industry founded/co-founded by Laura Shawver

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Bolden Therapeutics raised an undisclosed amount-Congrats Johnny Page Full Round Info: ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... 💸 BenchSci closed $95M Series D ...

linkedin.com

$32101650
OFF

Founder Lodge | Mission Therapeutics Raises $32,101,650 At …

6 days from now

Mar 15, 2024 · Mission Therapeutics raises $32,101,650 at Unknown on 2024-03-15 in Biotechnology Research, industry founded/co-founded by Anker Lundemose ... the Company …

founderlodge.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

6 days from now

Attovia Therapeutics raised $105,000,000 in Series B-Congrats Tao Fu Full Round Info: ... Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Goldman Sachs Asset Management …

linkedin.com

$226500000
OFF

Founder Lodge | Apollo Therapeutics Raises $226,500,000 At Series …

6 days from now

Sep 11, 2023 · Apollo Therapeutics raises $226,500,000 at Series C on 2023-09-11 in Biotechnology Research, industry founded/co-founded by Richard Mason

founderlodge.com

FAQs about Founder Lodge | Curve Therapeutics raises $51,183,495 at Series A … Coupon?

Who is curve Therapeutics?

SOUTHAMPTON, England, Feb. 27, 2024 /PRNewswire/ -- Curve Therapeutics ("Curve" or the "Company"), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the close of its successful £40.5 million Series A financing. ...

Who owns curve?

Curve originated from world-leading Microcycle® research conducted by Professor Tavassoli's group in the Department of Chemistry at the University of Southampton, UK. Curve is backed by blue chip investors including Advent Life Sciences, Epidarex Capital, Pfizer Ventures, Columbus Venture Partners and British Patient Capital. ...

Who are curve Therapeutics & epidarex capital?

They were joined by our founding investor Advent Life Sciences, and seed investor Epidarex Capital, underlining strong blue chip confidence behind Curve Therapeutics ' vision to transform the lives of patients by addressing disease targets which are intractable to conventional #drugdiscovery methods. ...

What is curve & Merck & Co?

Curve has a US$1.7bn global research collaboration with MSD the trade name of Merck & Co., Inc., Kenilworth, NJ USA, to discover and validate modulators of up to five therapeutic targets using its Microcycle® technology, initially for oncology and neurology indications. For more information visit: www.curvetx.com About Curve's Microcycle® platform ...

How much money did nocion Therapeutics raise?

Founder Lodge | 225+ Founders $3.2B Raised on LinkedIn: Nocion Therapeutics, Inc. raised $62,000,000 in Series B-Congrats Rick… ...

What's new at curve?

Curve occupies state of the art laboratories at the Southampton Science Park, a move prompted by the expansion of the Company's research team which included the recent appointments of Dr Monika Ermann as Vice President of Drug Discovery, and Dr Sally Price as Vice President of Biology. ...